IKT vs SPTK
Comparison between Inhibikase Therapeutics Inc (IKT, Company) and SportsTek Acquisition Corp - Class A (SPTK, Company).
IKT vs SPTK - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
IKT
$219M
SPTK
$219M
Max Drawdown
IKT
98.64%
Winner
SPTK
3.90%
Sharpe Ratio
IKT
0.08
Winner
SPTK
0.12
5Y Beta
IKT
1.38
SPTK
N/A
Industry
IKT
Biotechnology
SPTK
N/A
P/E Ratio
Winner
IKT
-3.23
SPTK
86.49
Debt to Equity
IKT
0.00%
SPTK
0.00%
Free Cash Flow Yield
IKT
-16.31%
Winner
SPTK
-0.43%
P/S Ratio
IKT
10.39
SPTK
N/A
P/B Ratio
IKT
1.31
Winner
SPTK
-29.56
IKT vs SPTK - Historical Returns
Returns include dividend reinvestment.
1M
IKT
-13.02%
Winner
SPTK
+1.40%
3M
IKT
-16.08%
Winner
SPTK
+3.26%
6M
Winner
IKT
+8.44%
SPTK
+3.78%
1Y
IKT
-12.57%
Winner
SPTK
+4.75%
5Y(CAGR)
IKT
-45.80%
SPTK
N/A
Max(CAGR)
IKT
-47.96%
Winner
SPTK
+0.87%
IKT vs SPTK - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | IKT | SPTK |
|---|---|---|
| 2026 | -14.36% | N/A |
| 2025 | -37.69% | N/A |
| 2024 | +144.03% | N/A |
| 2023 | -60.96% | N/A |
| 2022 | -69.70% | +4.21% |
| 2021 | -78.88% | -2.30% |
| 2020 | -30.30% | N/A |
IKT vs SPTK Drawdown Comparison
The maximum drawdown for IKT was -98.64%, occurring on Oct 9, 2023. This drawdown has not yet recovered.
The maximum drawdown for SPTK was -3.90%, occurring on Aug 20, 2021. Recovery took 403 trading sessions.
The current IKT drawdown is -97.19%. The current SPTK drawdown is -0.88%.
| Rank | IKT | SPTK |
|---|---|---|
| #1 | -98.64% Dec 23, 2020 - Oct 9, 2023 | -3.90% Apr 9, 2021 - Nov 11, 2022 |
| #2 | N/A | -2.15% Dec 15, 2022 - Dec 19, 2022 |
| #3 | N/A | -0.40% Nov 11, 2022 - Nov 29, 2022 |
| #4 | N/A | -0.30% Dec 7, 2022 - Dec 15, 2022 |
| #5 | N/A | -0.20% Nov 29, 2022 - Dec 7, 2022 |
Correlation
Correlation between IKT and SPTK is -0.56 which considered as a moderate negative correlation - the stocks show some tendency to move in opposite directions.
-0.56
-101
Select Stocks to Compare
Popular: IKT vs SPYSPTK vs SPY
More Comparisons
Compare with similar stocks